Small-cap investing continues to attract attention as India’s emerging businesses enter a high-growth phase. The Motilal Oswal Small Cap Fund – Direct Plan, launched in December 2023, is one of the newest entrants—but it has already delivered impressive early performance. This in-depth review explores its returns, portfolio strategy, risk profile, sectors, suitability, taxation, and whether it deserves a place in your long-term wealth plan.

1. Fund Overview: Key Highlights

Category: Equity – Small Cap
Launch Year: 2023
NAV (14 Nov 2025): ₹14.96
AUM: ₹5,830 crore (up from ₹4,084 crore)
Minimum SIP/Lump Sum: ₹500
Exit Load: 1% if redeemed within 365 days
Portfolio Size: 53 stocks
Avg Market Cap: ₹16,067 crore

The fund has experienced strong early traction, signaling rising investor confidence and consistent flows.

2. Performance Analysis: Strong Start for a New Fund

Tenure	Fund Return	Index Return (BSE 250 Small Cap TRI)
1-Year	47.68%	47.26%

The fund matched and slightly beat its benchmark—a strong outcome for a newly launched scheme navigating a volatile small-cap environment.

Quartile Performance:

2024: Rank 1/39
2025: Rank 12/43

This indicates early outperformance followed by stabilization as the AUM grew.

3. Portfolio Strategy: High-Quality Growth Focus

Portfolio Characteristics

P/E Ratio: 37.69 (growth-oriented)
P/B Ratio: 5.13 (premium valuations)
3-Year Earnings Growth: 42.06%

The fund emphasizes strong earnings momentum, selecting scalable, high-quality businesses with long-term potential.

Top 5 Holdings (17% concentration)

Dr. Agarwal’s Health Care – 4.08%
Karur Vysya Bank – 3.81%
CCL Products – 3.38%
Campus Activewear – 3.00%
MCX – 2.77%

The holdings show a blend of consumer brands, niche manufacturers, financials, and healthcare, ensuring both cyclicality and defensiveness.

4. Sector Allocation: Consumption-Led Growth Strategy

Sector	Allocation (%)
Consumer Discretionary	23.75
Financials	15.19
Healthcare	12.41
Industrials	11.39
Materials	11.22

The heavy tilt toward Consumer Discretionary reflects high confidence in India’s domestic demand and middle-class expansion trends.

Top Holdings (as of September 2025)

The fund’s portfolio reflects diversification across high-quality small-cap businesses with strong growth potential. The top holdings include:

Dr. Agarwal’s Health Care Ltd. – ~4.27%
Karur Vysya Bank Ltd. – ~3.73–3.81%
CCL Products (India) Ltd. – ~3.49%
Campus Activewear Ltd. – ~2.90%
VA Tech Wabag Ltd. – ~2.81%
Shaily Engineering Plastics Ltd. – ~2.71%
Rainbow Children’s Medicare Ltd. – ~2.66%
V2 Retail Ltd. – ~2.53%
CBLO – ~2.53%
Vijaya Diagnostic Centre Ltd. – ~2.41%
MCX India – ~2.37%

These holdings collectively represent leadership in healthcare, banking, consumer wear, engineering plastics, utilities, diagnostics, and speciality consumer categories. The allocation leans towards companies with proven scalability and consistent earnings profiles.

Fund Management Team

The fund is jointly managed by an experienced group of investment professionals:

Ajay Khandelwal – Lead Fund Manager
Niket Shah – Co-Fund Manager
Rakesh Shetty – Co-Fund Manager

The managers bring strong expertise in small-cap research, bottom-up stock picking, and identifying high-growth companies with sustainable competitive advantages.

Registrar / Transfer Agent (RTA)

The registrar for the fund is KFin Technologies Ltd., one of India’s largest and most trusted RTAs. It is responsible for investor servicing, transaction processing, record maintenance, and operational support.

Risk Details

1. Valuation Risk

Many holdings trade at relatively high price-to-earnings and price-to-book ratios. While this reflects growth potential, it also increases the risk of sharp corrections if earnings momentum slows.

2. Volatility & Liquidity Risk

Small-cap stocks generally experience significant price swings and lower liquidity. This means the fund may face sharper drawdowns during market corrections or high redemption periods.

3. Concentration Risk

The top 10–12 holdings form a meaningful portion of the portfolio. Underperformance of any major constituent could impact overall returns.

4. Fund Manager Risk

Although seasoned, the management team’s track record for this specific fund is still short. Long-term consistency is yet to be established given the fund was launched in December 2023.

5. Sector & Macro Risks

The fund’s sizable allocations toward consumer discretionary, healthcare, and financials make it sensitive to interest rate changes, demand cycles, and policy risks.

6. Exit Load Risk

A 1% exit load applies to redemptions within 365 days. This makes it unsuitable for short-term investors seeking liquidity or tactical rotation.

Key Risks Takeaway

High valuations may lead to sharp corrections
Liquidity challenges in small-cap stocks
Short performance history makes consistency untested
Heavy consumer-sector tilt
Higher volatility during market downturns

Risk Metrics (Category vs Index)

Std Deviation: 17.17 (Category), 18.88 (Index)
Sharpe Ratio: 0.89 (Category), 0.84 (Index)
Beta: 0.87 (Category)
R-Squared: 0.92

These indicate that while small caps are volatile, the category has delivered good risk-adjusted returns.

6. Suitability: Who Should Invest?

This fund is ideal for high-risk, long-term investors who want to capture India’s next-generation growth stories.

Suitable for:

Investors with 7+ years horizon
Those comfortable with volatility
SIP investors (preferred over lumpsum)
A satellite allocation of 15–20% of the equity portfolio

Not suitable for:

Short-term or conservative investors
Those who panic during market dips

7. Where This Fund Fits in Your Portfolio

Use it as a satellite (booster) investment to enhance overall equity returns.
Ideal combination:

70–80% in large & flexi-cap funds
15–20% in small-cap funds like this one

This balances stability and growth.

8. Taxation: Clear and Simple

Capital Gains

Long-Term (1+ year):
- Gains up to ₹1.25 lakh → Tax-free
- Above that → 12.5% tax
Short-Term (<1 year): 20% tax

Dividends

Added to income and taxed as per the slab
TDS of 10% if dividend > ₹10,000

9. Final Verdict: Should You Invest?

The Motilal Oswal Small Cap Fund – Direct Plan is off to a promising start, with strong early performance, a disciplined growth-oriented portfolio, and rising investor interest. While volatility and a limited track record remain factors, the fund’s structural positioning makes it a compelling option for long-term wealth creation.

Verdict:
✔ Good early signs
✔ Strong holdings & sector allocation
✔ Suitable for long-term SIP investors
✔ Use as supplementary (15–20%) allocation

Invest only if you can stay invested for 7+ years and withstand volatility.

Sources :

moneycontrol.com; Valueresearchonline.com; personalfn.com; etmoney.com; motilaloswalgroup.com; economictimes.indiatimes.com; Official fund factsheet disclosures

Discalimer!
The content provided in this blog article is for educational purposes only. The information presented here is based on the author's research, knowledge, and opinions at the time of writing. Readers are advised to use their discretion and judgment when applying the information from this article. The author and publisher do not assume any responsibility or liability for any consequences resulting from the use of the information provided herein. Additionally, images, content, and trademarks used in this article belong to their respective owners. No copyright infringement is intended on our part. If you believe that any material infringes upon your copyright, please contact us promptly for resolution.

Stock Market Resources & Articles

Motilal Oswal Small Cap Fund – Direct Plan: A Complete 2025 Analysis for Long-Term Investors